GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Capital Reinvestment Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Capital Reinvestment Ratio of 0.32x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.23 Billion) in capital expenditures (Rs389.75 Million). Check tangible equity quality of GlaxoSmithKline Pharmaceuticals Limited to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline Pharmaceuticals Limited Capital Reinvestment Ratio (2005–2025)
This chart tracks GlaxoSmithKline Pharmaceuticals Limited's Capital Reinvestment Ratio across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of GlaxoSmithKline Pharmaceuticals Limited.
Annual Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. See GlaxoSmithKline Pharmaceuticals Limited (GLAXO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | Rs12.90 Billion | Rs230.20 Million | ▼ -66.7% |
| 2024 | 0.05x | Rs5.82 Billion | Rs312.21 Million | ▼ -41.0% |
| 2023 | 0.09x | Rs4.84 Billion | Rs440.40 Million | ▲ +112.9% |
| 2022 | 0.04x | Rs8.11 Billion | Rs346.41 Million | ▼ -44.2% |
| 2021 | 0.08x | Rs5.78 Billion | Rs442.27 Million | ▼ -75.9% |
| 2020 | 0.32x | Rs4.90 Billion | Rs1.56 Billion | ▼ -56.4% |
| 2019 | 0.73x | Rs3.99 Billion | Rs2.91 Billion | ▼ -14.5% |
| 2018 | 0.85x | Rs4.73 Billion | Rs4.03 Billion | ▼ -33.9% |
| 2017 | 1.29x | Rs2.36 Billion | Rs3.04 Billion | ▼ -22.7% |
| 2016 | 1.67x | Rs1.39 Billion | Rs2.32 Billion | ▲ +245.5% |
| 2015 | 0.48x | Rs2.70 Billion | Rs1.30 Billion | ▲ +133.4% |
| 2014 | 0.21x | Rs2.81 Billion | Rs582.22 Million | ▲ +66.1% |
| 2013 | 0.12x | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs2.29 Billion | Rs93.72 Million | — |